Synopsis
0
JDMF
0
VMF
0
Canada
DRUG PRODUCT COMPOSITIONS
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
API SUPPLIERS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
USDMF
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]CEP/COS
LEBSA- Your strategic API source for niche molecules.
Certificate Number : R1-CEP 2003-099 - Rev 03
Status : Valid
Issue Date : 2019-09-02
Type : Chemical
Substance Number : 1490
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
Certificate Number : CEP 2002-208 - Rev 10
Status : Valid
Issue Date : 2024-05-27
Type : Chemical
Substance Number : 1490
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
Certificate Number : R0-CEP 2019-265 - Rev 00
Status : Withdrawn by Holder
Issue Date : 2020-03-26
Type : Chemical
Substance Number : 1490
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results] EU WC
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]KDMF
EUROAPI, the leading small molecules API player, provides both API sales & CDMO services.
Registrant Name : Sanofi-Aventis Korea Co., Ltd.
Registration Date : 2022-09-22
Registration Number : 20220922-209-J-1388
Manufacturer Name : Sanofi Winthrop Industrie
Manufacturer Address : 45 Chemin De Météline, Sisteron, 04200, France
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]NDC API
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Listed Suppliers
LEBSA- Your strategic API source for niche molecules.
About the Company : Lebsa is an innovative European laboratory that specializes in the synthesis, manufacture and commercialization of APIs with a focus on niche products. With a track record spanning...
Chynops Pharma is an ideal sourcing partner for high-quality APIs, advanced intermediates, speciality chemicals & excipients.
About the Company : Chynops Pharma, a company certified with ISO 9001:2015, is situated in Ahmedabad, India. We specialize in exporting, supplying, and trading a wide range of products, including APIs...
EUROAPI, the leading small molecules API player, provides both API sales & CDMO services.
About the Company : EUROAPI is focused on reinventing active ingredient solutions to meet the needs of customers and patients worldwide sustainably. We are a leading player in APIs with approximately ...
LGM Pharma accelerates & optimizes the new product pathway from early development through commercialization.
About the Company : LGM Pharma is a global leader in sourcing hard-to-find APIs and intermediates for the pharmaceutical and biotech industries. LGM is also a full service CDMO providing formulation, ...
Jai Radhe Sales is your partner for all your sourcing needs.
About the Company : Jai Radhe Sales was founded in 1999 as an out-of-the-box distribution firm specializing in the global supply of high-quality pharmaceutical ingredients. The firm provides complete ...
HRV Global Life Sciences - Market Expansion Leader in Pharmaceuticals.
About the Company : HRV Global is a leading global manufacturer, seller & exporter of a wide range of APIs, advanced intermediates, pellets, food grade chemicals, food additives & food ingredients. It...
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]API Reference Price
API/FDF Prices: Book a Demo to explore the features and consider upgrading later
API Imports and Exports
Drugs in Development
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]INTERMEDIATE SUPPLIERS
EUROAPI, the leading small molecules API player, provides both API sales & CDMO services.
2-Methoxyl-4-amino-5- ethylsulfonylbenzoic acid
CAS Number : 71675-87-1
End Use API : Amisulpride
About The Company : EUROAPI is focused on reinventing active ingredient solutions to meet the needs of customers and patients worldwide sustainably. We are a leading player in APIs...
EUROAPI, the leading small molecules API player, provides both API sales & CDMO services.
Methyl 4-acetamido-5-iodo-2- methoxybenzoate
CAS Number : 201214-53-1
End Use API : Amisulpride
About The Company : EUROAPI is focused on reinventing active ingredient solutions to meet the needs of customers and patients worldwide sustainably. We are a leading player in APIs...
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]FDF Dossiers
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]FDA Orange Book
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Europe
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Australia
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Digital Content
NEWS #PharmaBuzz
Global Sales Information
Market Place
APIs
Reply
27 Apr 2024
Reply
16 Feb 2023
Reply
30 Jun 2022
Reply
02 May 2022
Reply
22 Apr 2022
Reply
04 Nov 2020
Reply
12 Feb 2020
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
REF. STANDARDS & IMPURITIES
ABOUT THIS PAGE
83
PharmaCompass offers a list of Amisulpride API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Amisulpride manufacturer or Amisulpride supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Amisulpride manufacturer or Amisulpride supplier.
PharmaCompass also assists you with knowing the Amisulpride API Price utilized in the formulation of products. Amisulpride API Price is not always fixed or binding as the Amisulpride Price is obtained through a variety of data sources. The Amisulpride Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Amisulpride manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Amisulpride, including repackagers and relabelers. The FDA regulates Amisulpride manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Amisulpride API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Amisulpride manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Amisulpride supplier is an individual or a company that provides Amisulpride active pharmaceutical ingredient (API) or Amisulpride finished formulations upon request. The Amisulpride suppliers may include Amisulpride API manufacturers, exporters, distributors and traders.
click here to find a list of Amisulpride suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Amisulpride DMF (Drug Master File) is a document detailing the whole manufacturing process of Amisulpride active pharmaceutical ingredient (API) in detail. Different forms of Amisulpride DMFs exist exist since differing nations have different regulations, such as Amisulpride USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Amisulpride DMF submitted to regulatory agencies in the US is known as a USDMF. Amisulpride USDMF includes data on Amisulpride's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Amisulpride USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Amisulpride suppliers with USDMF on PharmaCompass.
In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.
Pharmaceutical companies submit a Amisulpride Drug Master File in Korea (Amisulpride KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of Amisulpride. The MFDS reviews the Amisulpride KDMF as part of the drug registration process and uses the information provided in the Amisulpride KDMF to evaluate the safety and efficacy of the drug.
After submitting a Amisulpride KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their Amisulpride API can apply through the Korea Drug Master File (KDMF).
click here to find a list of Amisulpride suppliers with KDMF on PharmaCompass.
A Amisulpride CEP of the European Pharmacopoeia monograph is often referred to as a Amisulpride Certificate of Suitability (COS). The purpose of a Amisulpride CEP is to show that the European Pharmacopoeia monograph adequately controls the purity of Amisulpride EP produced by a given manufacturer. Suppliers of raw materials can prove the suitability of Amisulpride to their clients by showing that a Amisulpride CEP has been issued for it. The manufacturer submits a Amisulpride CEP (COS) as part of the market authorization procedure, and it takes on the role of a Amisulpride CEP holder for the record. Additionally, the data presented in the Amisulpride CEP (COS) is managed confidentially and offers a centralized system acknowledged by numerous nations, exactly like the Amisulpride DMF.
A Amisulpride CEP (COS) is recognised by all 36 nations that make up the European Pharmacopoeia Convention. Amisulpride CEPs may be accepted in nations that are not members of the Ph. Eur. at the discretion of the authorities there.
click here to find a list of Amisulpride suppliers with CEP (COS) on PharmaCompass.
A Amisulpride written confirmation (Amisulpride WC) is an official document issued by a regulatory agency to a Amisulpride manufacturer, verifying that the manufacturing facility of a Amisulpride active pharmaceutical ingredient (API) adheres to the Good Manufacturing Practices (GMP) regulations of the importing country. When exporting Amisulpride APIs or Amisulpride finished pharmaceutical products to another nation, regulatory agencies frequently require a Amisulpride WC (written confirmation) as part of the regulatory process.
click here to find a list of Amisulpride suppliers with Written Confirmation (WC) on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Amisulpride as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Amisulpride API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Amisulpride as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Amisulpride and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Amisulpride NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Amisulpride suppliers with NDC on PharmaCompass.
Amisulpride Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Amisulpride GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Amisulpride GMP manufacturer or Amisulpride GMP API supplier for your needs.
A Amisulpride CoA (Certificate of Analysis) is a formal document that attests to Amisulpride's compliance with Amisulpride specifications and serves as a tool for batch-level quality control.
Amisulpride CoA mostly includes findings from lab analyses of a specific batch. For each Amisulpride CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Amisulpride may be tested according to a variety of international standards, such as European Pharmacopoeia (Amisulpride EP), Amisulpride JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Amisulpride USP).
Comment (2)
